日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy

探索代谢疗法在卵巢上皮癌治疗中的应用

Kumari, Sangeeta; Gupta, Shraddha; Jamil, Aisha; Tabatabaei, Deyana; Karakashev, Sergey

Mouse models of epithelial ovarian cancer for preclinical studies

用于临床前研究的上皮性卵巢癌小鼠模型

Karakashev, Sergey; Zhang, Ru-Gang

Targeting CARM1 in ovarian cancer with EZH2 and PARP inhibitors

利用 EZH2 和 PARP 抑制剂靶向治疗卵巢癌中的 CARM1

Karakashev, Sergey; Zhang, Rugang

CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity.

表达 CARM1 的卵巢癌依赖于组蛋白甲基转移酶 EZH2 的活性

Karakashev Sergey, Zhu Hengrui, Wu Shuai, Yokoyama Yuhki, Bitler Benjamin G, Park Pyoung-Hwa, Lee Jeong-Heon, Kossenkov Andrew V, Gaonkar Krutika Satish, Yan Huihuang, Drapkin Ronny, Conejo-Garcia Jose R, Speicher David W, Ordog Tamas, Zhang Rugang

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy

克服缺氧诱导的实体瘤治疗耐药性方面取得的进展

Karakashev, Sergey V; Reginato, Mauricio J

The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance

癌基因HER2/neu(ERBB2)需要缺氧诱导因子HIF-1才能促进乳腺肿瘤生长并抵抗细胞凋亡。

Whelan, Kelly A; Schwab, Luciana P; Karakashev, Sergey V; Franchetti, Lisa; Johannes, Gregg J; Seagroves, Tiffany N; Reginato, Mauricio J